Development of a cell system for siRNA screening of pathogen responses in human and mouse macrophages

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Li, Ning ^a   Sun, Jing ^a   Benet, Zachary L ^a   Wang, Ze ^a   Al Khodor, Souhaila ^a   John, Sinu P ^a   Lin, Bin ^a   Sung, Myong Hee ^b   Fraser, Iain D C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR;

ANIMAL; CELL LINE; CLUSTER ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ORDER; GENE TRANSFER; GENE VECTOR; GENETICS; GRAM NEGATIVE INFECTION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LENTIVIRINAE; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; PROCEDURES; PROMOTER REGION; REPORTER GENE; REPRODUCIBILITY; RNA INTERFERENCE;

ANIMALS; CELL LINE; CLUSTER ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ORDER; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; LENTIVIRUS; LIGANDS; MACROPHAGES; MICE; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTORS;

EID: 84926384947     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09559     Document Type: Article

References (36)

1. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801, doi:10.1016/j.cell.2006.02.015 (2006).
2. Beutler, B. A. TLRs and innate immunity. Blood 113, 1399-1407, doi:10.1182/blood-2008-07-019307 (2009).
3. Foster, S. L. & Medzhitov, R. Gene-specific control of the TLR-induced inflammatory response. Clinical immunology 130, 7-15, doi:10.1016/j.clim.2008.08.015 (2009).
4. Creagh, E. M. & O'Neill, L. A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends in immunology 27, 352-357, doi:10.1016/j.it.2006.06.003 (2006).
5. Ostuni, R., Zanoni, I. & Granucci, F. Deciphering the complexity of Toll-like receptor signaling. Cellular and molecular life sciences: CMLS 67, 4109-4134, doi:10.1007/s00018-010-0464-x (2010).
6. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811, doi:10.1038/35888 (1998).
7. Boutros, M. & Ahringer, J. The art and design of genetic screens: RNA interference. Nat Rev Genet 9, 554-566, doi:10.1038/nrg2364 (2008).
8. Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498, doi:10.1038/35078107 (2001).
9. Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732-738, doi:10.1038/35099560 (2001).
10. Heil, F. et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526-1529, doi:10.1126/science.1093620 (2004).
11. Lund, J. M. et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 101, 5598-5603, doi:10.1073/pnas.0400937101 (2004).
12. Judge, A. D. et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 23, 457-462, doi:10.1038/nbt1081 (2005).
13. Cekaite, L., Furset, G., Hovig, E. & Sioud, M. Gene expression analysis in blood cells in response to unmodified and 2′-modified siRNAs reveals TLR-dependent and independent effects. Journal of molecular biology 365, 90-108, doi:10.1016/j.jmb.2006.09.034 (2007).
14. Tsuchiya, S. et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). International journal of cancer. Journal international du cancer 26, 171-176 (1980).
15. Raschke, W. C., Baird, S., Ralph, P. & Nakoinz, I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15, 261-267 (1978).
16. Birmingham, A. et al. Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods 6, 569-575, doi:10.1038/nmeth.1351 (2009).
17. Fleit, H. B. & Kobasiuk, C. D. The human monocyte-like cell line THP-1 expresses Fc gamma RI and Fc gamma RII. Journal of leukocyte biology 49, 556-565 (1991).
18. Park, E. K. et al. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflammation research: official journal of the European Histamine Research Society... [et al.] 56, 45-50, doi:10.1007/s00011-007-6115-5 (2007).
19. Sung, M. H. et al. Switching of the relative dominance between feedback mechanisms in lipopolysaccharide-induced NF-kappaB signaling. Sci Signal 7, ra6, doi:10.1126/scisignal.2004764 (2014).
20. Vandamme, P. et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol 47, 1188-1200 (1997).
21. Nzula, S., Vandamme, P. & Govan, J. R. Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 50, 265-269 (2002).
22. Bernhardt, S. A., Spilker, T., Coffey, T. & LiPuma, J. J. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 37, 780-785, doi:10.1086/377541 (2003).
23. Coenye, T. & LiPuma, J. J. Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes. Microbiology 149, 77-88 (2003).
24. Mahenthiralingam, E., Urban, T. A. & Goldberg, J. B. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3, 144-156, doi:10.1038/nrmicro1085 (2005).
25. Al-Khodor, S. et al. Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages. Cellular microbiology 16, 378-395, doi:10.1111/cmi.12223 (2014).
26. Brass, A. L. et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926, doi:10.1126/science.1152725 (2008).
27. Konig, R. et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49-60, doi:10.1016/j.cell.2008.07.032 (2008).
28. Zhou, H. et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4, 495-504, doi:10.1016/j.chom.2008.10.004 (2008).
29. Brass, A. L. et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254, doi:10.1016/j.cell.2009.12.017 (2009).
30. Shapira, S. D. et al. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139, 1255-1267, doi:10.1016/j.cell.2009.12.018 (2009).
31. Karlas, A. et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463, 818-822, doi:10.1038/nature08760 (2010).
32. Konig, R. et al. Human host factors required for influenza virus replication. Nature 463, 813-817, doi:10.1038/nature08699 (2010).
33. Lacaze, P. et al. Combined genome-wide expression profiling and targeted RNA interference in primary mouse macrophages reveals perturbation of transcriptional networks associated with interferon signalling. BMC Genomics 10, 372, doi:10.1186/1471-2164-10-372 (2009).
34. Hemmi, H. et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3, 196-200, doi:10.1038/ni758 (2002).
35. Jurk, M. et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 3, 499, doi:10.1038/ni0602-499 (2002).
36. Wall, E. A. et al. Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105. Sci Signal 2, ra28, doi:10.1126/scisignal.2000202 (2009).